End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
174,100 KRW | -1.80% | -1.58% | +76.75% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Evolution of the average Target Price on ALTEOGEN Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- A196170 Stock
- Consensus ALTEOGEN Inc.